Clinical Trials Browser

Phase 2 × NIH × Biochemical Recurrent Prostate Cancer × Clear all

NCT04206319 2026-03-16

Radium-223 in Biochemically Recurrent Prostate Cancer

Phase 2 Active not recruiting

Biochemical Recurrent Prostate Cancer